Related Experiment Video
Updated: Nov 5, 2025
09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.7K
Arachidonic Acid Metabolites in Neurologic Disorders.
Oguzhan Kursun1, Hulya Karatas2, Hulagu Bariskaner3
1Department of Neurology Clinic, Ankara City Hospital, Neurointensive Care Unit, Ankara, Turkey.
CNS & Neurological Disorders Drug Targets
|May 13, 2021
Summary
Arachidonic acid (ARA) plays a crucial role in cell membrane function and inflammation. This review explores ARA
Area of Science:
- Biochemistry
- Neuroscience
- Immunology
Background:
- Arachidonic acid (ARA) is vital for cell membrane integrity and function, especially in neural and immune systems.
- ARA metabolites are key players in inflammatory responses, vascular reactivity, and neurological processes.
- ARA is the second most abundant polyunsaturated fatty acid in nerve cell membranes.
Purpose of the Study:
- To review the role of arachidonic acid (ARA) and its metabolites in neurological disorders.
- To discuss experimental and human study findings on ARA in the context of neurologic conditions.
- To explore potential treatment options related to ARA pathways in neurological diseases.
Main Methods:
- Literature review of experimental studies.
- Analysis of human study results.
- Synthesis of findings on ARA and neurological disorders.
Main Results:
- ARA metabolites are implicated in acute inflammation and possess pro-resolving properties.
- ARA derivatives, particularly via COX enzymes, regulate vascular reactivity.
- Significant involvement of ARA metabolites is observed in neurodegenerative diseases and stroke.
Conclusions:
- Arachidonic acid (ARA) and its metabolites are critically involved in various neurological disorders.
- Understanding ARA pathways offers insights into potential therapeutic strategies for conditions like Alzheimer's, Parkinson's, and stroke.
More Related Videos
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
1.7K
08:14Extraction of Non-Protein Amino Acids from Cyanobacteria for Liquid Chromatography-Tandem Mass Spectrometry Analysis
Published on: December 9, 2022
4.0K
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
1.8K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.8K
01:26Neurochemical Transmission: Sites of Drug Action
3.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.1K
01:26Alzheimer's Disease: Overview
958
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
958
01:22Alzheimer's Disease: Treatment
467
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
467
01:23Role of Neurotransmitters in Memory
1.8K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
1.8K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.3K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.3K